Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+16.4%
5Y CAGR+344.9%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+16.4%/yr
Annual compound
5Y CAGR
+344.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
1742.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$26.14M+169.5%
2023$9.70M+2032.1%
2022$455000.00-97.3%
2021$16.58M-
2020$0.00-100.0%
2019$15000.00-40.0%
2018$25000.00-